More than 95% of CAH is caused by decreased activity of 21-hydroxylase (21-OH) due to mutations in the 21-hydroxylase (CYP21A2) gene (2, 3), thus this form will be addressed in our review. The gene discussed is CYP21A2; the disease is congenital adrenal hyperplasia.